- Price:
- $25.73
- Open:
- $25.74
- Previous close:
- $25.70
- Day's range:
- $25.59 - $26.10
- Year's range:
- $24.48 - $31.54
- Net Income per Share:
- 0.75
- Price-to-Earnings ratio:
- 34.31
- 52-week Price Range:
- $27.60
- Volume:
- $25,545,340.00
- Average volume:
- $39,120,001.00
Company profile for Pfizer Inc.
Pfizer Inc., one of the largest pharmaceutical companies in the world, is a biopharmaceutical company that discovers, develops, manufactures, markets, distributes and sells medical products. It has a long history of over 170 years of providing healthcare solutions, with a dedication to providing medications and vaccines for therapeutic areas such as cardiovascular and metabolic health, women’s health, biologics and small molecules, immunotherapies and biosimilars.
The company has a diverse portfolio of products and brands, making it a leader in providing medicines and vaccine solutions. These include Premarin family and Eliquis brands for cardiovascular and metabolic health; Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands for biologics, small molecules and immunotherapies; and Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands for sterile injectable and anti-infective medicines, and oral COVID-19 treatment. Additionally, Pfizer offers medicines and vaccines for diseases such as pneumococcal disease, meningococcal disease, tick-borne encephalitis and Covid-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba and Prevnar family brands. It also has a range of biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo brands, and amyloidosis, hemophilia and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX and Genotropin brands.
In addition to its product portfolio, Pfizer Inc. is a leader in the contract manufacturing industry, providing services to wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices and other health service centers. The company has several collaborations and partnerships with leading CMOs such as Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Akcea Therapeutics, Inc, Merck KGaA, Valneva SE, BioNTech SE and Arvinas, Inc.
Pfizer Inc. was founded in 1849 in New York City and is headquartered in New York, New York. The company operates in around 150 countries and has an employee base of over 90,000 individuals. Among the many awards it has received, Pfizer was recognized by DiversityInc’s 2020 Specialty List: Top 10 Companies for Supplier Diversity and named to Fortune Magazine’s list of World’s Most Admired Companies in 2019. Additionally, in 2020, the company was named to Fortune’s list of 100 Best Companies to Work For and was included in Barron’s 100 Most Sustainable Companies list.
Pfizer Inc. has a long history of contribution to healthcare and scientific research, including its recent involvement in the development and production of a vaccine for Covid-19. In addition, some of the company’s recent initiatives have included the launch of the Pfizer Research Partnership Program to support research projects on topics such as real-world evidence and patient-level data, the launch of the Pfizer Oncology Venture Fund, and the launch of the Pfizer Translational Science Center, which is dedicated to advancing the most promising areas of medical research.
- Stock exchanges:
- NYSE
- Sector:
- Healthcare
- Industries:
- Drug Manufacturers
- Ticker:
- PFE
- CIK:
- 78003
- ISIN:
- US7170811035
- Website:
- https://www.pfizer.com
- Phone:
- 212 733 2323
- Origin:
- United States
- Employees:
- 79,000